Release 5

This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Example EvidenceVariable/example-alteplase-for-stroke (Narrative)

Clinical Decision Support Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile EvidenceVariable.

"Alteplase for Stroke" is an exposure concept with a detailed dosing instruction that may be used in expressing what an Evidence is about.

 

Other examples that reference this example:

  • Evidence/Risk of mRS3-6 at 90 days after Alteplase for Stroke if ASTRAL score 12
  • Evidence/Effect of Alteplase vs No alteplase on mRS 3-6 at 90 days in Stroke 0-3 hours prior
  • Evidence/Effect of Alteplase vs No alteplase on mRS 0-2 at 90 days in Stroke 3-4.5 hours prior

    •  

    Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.